BCL2 and diffuse large B-cell lymphoma: Intriguingly, within diffuse large B-cell lymphoma (DLBCL), MNDA expression is more prevalent in the non-germinal center B-cell (non-GCB) subtype and the BCL2/MYC double-expression group, displaying a correlation with CD5 expression—a finding that merits further exploration.